Exelixis



Ebitda Cambio Fecha
Acadia Pharmaceuticals USD 12.2M 22.01M 2024-12
Agios Pharmaceuticals USD -105351000 18.32M 2025-03
Amgen USD 3.75B 42M 2025-03
AstraZeneca USD 5.08B 182M 2025-03
Bayer EUR 1.67B 3.36B 2024-12
BioMarin Pharmaceutical USD 245.96M 51.11M 2025-03
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Cytokinetics USD -136657000 1.73M 2024-12
Eisai JPY 37.6B 13.2B 2024-12
Eli Lilly USD 4.16B 2B 2025-03
Exelixis USD 171.1M 24.2M 2025-01
Genmab DKK 2.23B 85M 2024-09
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Incyte USD 222.66M 97.54M 2025-03
Ionis Pharmaceuticals USD -141463000 35.91M 2025-03
MacroGenics USD -50784000 106.81M 2024-12
Merck USD 7.74B 625M 2025-03
Moderna USD -924000000 69M 2025-03
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 5.19B 319M 2024-12
Pfizer USD 6.21B 1.5B 2025-03
Sanofi EUR 563M 3.93B 2024-12
Takeda JPY 254.6B 125.66B 2024-12
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
Xencor USD 7.14M 64.97M 2024-12



Exelixis - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.